Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 64EUX713G6

Pharmacology

Action Mechanism of Action Reference
INHIBITOR OX-2 membrane glycoprotein inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Leukemia, Myeloid, Acute 1 D015470 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1073059-33-2
ChEMBL CHEMBL1743067
FDA SRS 64EUX713G6